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1. Introduction 
Glandular lesions of the female genital tract have always been a challenge for 
pathologists. The precise cytological diagnosis of these lesions is difficult because of their 
inherent complexity, as well as the lack of experience of many cytopathologists in this 
field. 
The term atypical glandular cells of undetermined significance (AGUS) was first  introduced 
at the 1988 Bethesda Conference (National Cancer Institute Workshop, 1989) and defined as 
morphologic changes in glandular cells beyond those suggestive a benign reactive process, 
but insufficient for the interpretation of adenocarcinoma. In the 2001 Bethesda System (TBS 
2001) (Solomon, 2002), the term has been changed to better reflect current knowledge and 
understanding of glandular neoplasia. The category has been defined and renamed 
“atypical glandular cells” (AGC), with the subclassifications “not otherwise specified” 
(AGC-NOS) and “favor neoplastic” (AGC-FN). The cell type of origin, endocervical or 
endometrial, should be addressed whenever possible. Adenocarcinoma in situ has been 
separated as another distinct category of diagnosis.  
In 2006, the American Society for Colposcopy and Cervical Pathology (ASCCP) released 
consensus guidelines for the management guidelines for the management of AGC (Wright, 
2007). The guidelines emphasized combined colposcopy and endocervical sampling was 
recommended for all women across all subcategories of AGC, with the addition of 
endometrial sampling for women over 35. So, since 2006, more comprehensive evaluations 
were applied for these women. Recent studies concerning the follow-up outcomes of AGC 
revealed more patients with precancerous or malignant diseases of different sites ranging 
from the exo-cervix, endocervix, endometrium, fallopian tube, ovary and even extra-genital 
organs (Behtash, 2007; Duska, 1998; Jeng, 2003; Koonings, 2001; Lai, 2008; Manetta, 1999; 
Mood, 2006; Soofer, 2000). Since the introduction of Pap smear screening, the incidence of 
cervical squamous cell carcinoma has been dramatically declined but the relative incidence 
of glandular cancer has been increased. However, the sensitivity of detecting cervical 
glandular precancerous or cancer lesions is much less than that of the squamous lesions 
making cervical glandular cancer prevention remains a challenge and problem to be solved 
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(Koss, 1989; Wingo, 2003). So, our ability to recognize and diagnose AGC-NOS or AGC-FN 
is very important. After correct triage of patients with AGC Pap smears, early treatment of 
these lesions may be achieved. The protective effects of cytologic screening for glandular 
lesions can be then improved.  
In our previous study (Lai, 2008), it supported the view that a diagnosis of AGC is clinically 
significant by the 2001 Bethesda System, especially the AGC-FN category. The 
subclassification of AGC is important and demanded in the diagnosis of Pap smears. 
Addressing the cell origin of endometrium, although being found no statistically significant 
difference, it showed a more common significant pathology outcome. Since then, we still 
followed the 2001 Bethesda System to subclassify and address the cell origin in AGC Pap 
smears. As to management protocol, we strongly recommend following the ASCCP 
consensus guidelines. In the current retrospective study of 9 years experience, histological 
follow-up results obtained and paired to the corresponding cytology interpretation, and the 
results further enhanced the importance of the role of the Pap smear diagnosis of AGC in 
screening and diagnosing the precancerous and cancer lesions. 
2. Materials and methods 
A retrospective review of the archives of the Department of Pathology, Taipei Veterans 
General Hospital, from January 2002 to December 2010 identified 234 smears diagnosed as 
AGC with at least 6 months follow-up. All of the Pap smears since January 2002 were 
diagnosed and classified according to the 2001 Bethesda System criteria at the time of 
diagnosis. If cellular findings suggestive of endometrial glandular or stromal cells were 
noted, the description of “endometrial origin” would be made in the space of 
“educational notes and suggestion” in the cytologic report. An adequate evaluation for 
AGC Pap smears suggested by the ASCCP included a colposcopy with or without cervical 
biopsy, endocervical curettage and an endometrial sampling, especially in those patients 
in whom endometrial origin was addressed in the Pap test. In addition, those patients 
who received other diagnostic or treatment procedures such as conization, loop 
electrosurgical excision procedure (LEEP) or hysterectomy were also included in this 
study. The most abnormal histology was considered to be the outcome. Patients who 
failed to receive the management described even with multiple repeated pap smears were 
excluded in the evaluation. 
The clinical information of patient, such as age, menopausal status, hormonal replacement 
therapy status, tamoxifen use status, and presence of abnormal bleeding were collected from 
medical record. Pathology findings of endometrial biopsy were categorized as benign, 
precursors (high grade squamous intra-epithelial lesion, endocervical adenocarcinoma in 
situ, endometrial atypical complex hyperplasia), and malignant. The precursors and 
malignant pathology results are defined as abnormal pathology. Based on cyto-histological 
and available clinical data, we made meticulous description of the cytological findings 
including atypical glandular cells themselves and the background pattern and statistical 
analyses on the different subclassifications of AGC by using Chi-square test and 
multivariate logistic regression. A P value <0.05 was considered to be statistically 
significant. 
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3. Results 
3.1 Pathology results 
From a total of 228,451 cervicovaginal cytologic specimens within a 9-year period from 
January 2002 to December 2010, a total of 234 (0.1%) AGC Pap smears were identified. The 
age distribution ranged from 27 to 93 years (median 49). All were conventional Pap smears 
and primarily carried out for cervical cancer screening. 190 of 234 (81%) cases with adequate 
histologic evaluation were included in this study. (Table 1)  
AGC subtype Number  Histologic follow-up (%) 
AGC-NOS 197 157 (80%) 
AGC-FN 37 33 (89%) 
Total 234 190 (81%)  
AGC: atypical glandular cells 
AGC-NOS: atypical glandular cells, not otherwise specified 
AGC-FN: atypical glandular cells, favor neoplastic 
Table 1. Histologic follow-up rates by AGC subtype  
Adequate initial evaluation for AGC Pap smears suggested by the ASCCP included a 
colposcopy with or without cervical biopsy, endocervical curettage and an endometrial 
sampling, especially in those patients endometrial origin was addressed in the Pap test. 
Abnormal histology of precursors and invasive lesions were found in 76 patients (40%) 
(Table 2) Final pathology results included 37 endometrial adenocarcinomas, 6 endocervical 
adenocarcinomas, 1 cervical squamous cell carcinoma, 1 endometrial malignant mixed 
Mullerian tumor (MMMT), 3 ovarian carcinomas, 3 colon-rectal adenocarcinomas, 1 
fallopian tube adenocarcinoma, 4 endocervical adenocarcinoma in situ, 2 endocervical 
glandular dysplasia, 6 high grade squamous intraepithelial lesion (HSIL), and 11 
endometrial complex hyperplasia. Invasive diseases, accounting for 28% (53 of 190) were 
much more common than precursors, 12% (23 of 190). All of the patients with significant 
pathology received definitive treatment, including complete staging surgery for those 
harboring invasive neoplastic diseases.  
There were 83 smears sub-classified as AGC-NOS; 75 as AGC-NOS, endometrial origin 
(EM); 21 as AGC-N, endometrial origin (EM); 11 as AGC-N. The subgroup of AGC-N, EM 
had the highest rate of abnormal pathology, followed by AGC-NOS, EM, AGC-N and AGC-
NOS; 18 of 21 (86%), 30 of 75 (40%), 4 of 11 (36%) and 24 of 83 (29%), respectively. The 
difference was significant. (P<0.001) Women with AGC-N were more likely to have 
significant pathology (22 in 32 (69%)) compared with those with AGC-NOS (54 in 158 
(34%)). It was statistically significant. (P<0.001) The endometrial origin addressed cases had 
more abnormal pathology results than those not being addressed, 48 of 96 (50%) v.s. 28 of 94 
(30%). (P=0.004) (Table 3) 
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Histologic results Cases (%) 
Benign 114  (60%) 
Abnormal 76   (40%) 
Invasive lesions 53 (28%) 
   Cervical cancer 7 
   Adenocarcinoma 6  
   Squamous cell carcinoma 1 
   Endometrial cancer 38 
   Adenocarcinoma 37 
   Malignant mixed Müllerian tumor 1 
   Extra-uterine malignancies 8  
   Ovary carcinoma 3  
   Rectal cancer  4  
   Tubal carcinoma 1  
Precursor lesions 23 (12%) 
Endocervical glandular dysplasia 2 
Endocervical adenocarcinoma in situ 4  
High grade squamous intraepithelial lesion 6 
Endometrial complex hyperplasia (including atypical) 11 
Table 2. Final Histologic results of 190 patients with AGC Pap smears 
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 N Benign Abnormal P 
Diagnostic category     
AGC-NOS, EM 75 45 (60%) 30 (40%) <0.0011 
AGC-NOS 83 59 (71%) 24 (29%)  
AGC-FN, EM 21 3 (14%) 18 (86%)  
AGC-FN 11 7 (64%) 4 (36%)  
EM     
Address 96 48 (50%) 48 (50%) 0.0041 
Not address 94 66 (70%) 28 (30%)  
Favor neoplastic     
Yes 32 10 (31%) 22(69%) <0.0011 
No 158 104 (66%) 54 (34%)   
Total cases 190 114 (60%) 76 (40%)  
1chi-square test 
EM: endometrial origin 
Table 3. Abnormal histologic results in different AGC subtypes 
3.2 Cytologic findings and differential diagnoses 
Degenerative atypical endometrial glandular cells admixed with endometrial debris 
indicated endometrial origin, The endometrial debris distributed along the smearing 
direction (Figure 1-3) was characterized by watery diatheses, foamy histiocytes, 
degenerative necrotic debris and phagocytosis (Figure 4). Some or all of the above findings 
were observed in 1 fallopian tube adenocarcinoma , 25 endometrial adenocarcinomas and 1 
MMMT but none of the cervical lesions and other extra-uterine cancers.  
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Fig. 1. The endometrial debris distributed along the smearing direction in the background. 
(Papanicolaou stain, 100x) 
 
 
 
 
 
 
Fig. 2. Degenerative atypical endometrial glandular cells, favor neoplastic (arrow head), 
admixed with endometrial debris. The final pathology turned out to be an endometrioid 
adenocarcinoma, grade II. (Papanicolaou stain, 200x) 
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Fig. 3. The higher magnification showed tight cluster of atypical endometrial glandular cells 
with degeneration, high N/C ratio, three-dimensional structure, and small faint nucleoli. 
These features fall short of diagnosing an adenocarcinoma directly, either in quantity or 
quality. (Papanicolaou stain, 400x) 
 
Fig. 4. The endometrial debris was characterized by watery diatheses, foamy histiocytes, 
degenerative necrotic debris and phagocytosis. It was very specific for endometrial lesions. 
(Papanicolaou stain, 400x) 
The distribution pattern, along the smearing direction, was very characteristic for this kind 
of debris indicating shedding from endometrium instead of endocervix. However, it would 
disappear in the fluid-based preparations. In addition, mucin substance was always absent 
in the endometrial debris. On the contrary, we noticed that a characteristic finding 
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consisting of necrosis and a mucinous background resembling the pattern seen in ileal 
conduit urine was an indicator suggestive of endocervical adenocarcinoma (Figure 5-8).  
This feature was seen in 3 of the 6 endocervical adenocarcinomas but none of the other 
cancers.  
 
Fig. 5. Background of mucin streaks admixed with necrotic mucous cells resembling those of 
an ileal conduit urine specimen. (Papanicolaou stain, 200x) 
 
 
 
Fig. 6. Background mucin streaks are very thick and have characteristic color and 
distribution. (Papanicolaou stain, 100x) 
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Fig. 7. Ileal conduit urine like features contained abundant degenerative glandular mucous 
cells and debris. (Papanicolaou stain, 200x) 
Recognizing this dirty mucin background would be very important in the interpretation of 
AGC Pap smears and helped the clinicians successfully found the primary site of cancers.  
Endometrial debris admixed with atypical endometrial glandular cells would be seen not 
only in the cancer patients but also in benign lesions, such as endometrial polyp and intra-
uterine contraceptive device (Figure 9-10). Clinical information is very important to avoid 
over diagnosis.  
 
Fig. 8. These degenerative mucous cells had small eccentric hyperchromatic nuclei and 
abundant mucous cytoplasm indicating mucinous glandular origin. (Papanicolaou stain, 400x) 
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Fig. 9. Degenerative atypical endometrial glandular cells and endometrial debris were noted 
in a smear of patient with intra-uterine contraceptive device (IUD). Originally, the diagnosis 
of AGC-NOS, EM was given without knowing the IUD situation. (Papanicolaou stain, 200x) 
 
Fig. 10. Higher magnification showed small three-dimensional group of endometrial 
glandular cells with characteristic cytoplasmic vacuolation and slightly enlarged 
hyperchromatic nuclei. (Papanicolaou stain, 400x) 
The major differential diagnoses of atypical endocervical glandular cells include 
adenocarcinoma in situ (Figure 11), tubal metaplasia (Figure 12) and lower uterine segment 
cells (Figure 13). When the lesion is adequately sampled and the abnormal cells are well 
visualized both quantitatively and qualitatively, the diagnosis will be no problem in most 
circumstances. Otherwise, these look-alike entities should be taken into the list of 
differential diagnoses.  
www.intechopen.com
 The Role of the Pap Smear Diagnosis: Atypical Glandular Cells (AGC) 
 
375 
 
 
Fig. 11. Super-crowded endocervical glandular cells presenting pseudostratification and 
feathering edge. The nuclei are elongated and hyperchromatic with high N/C ratio.  
Nucleoli are absent. However, only two fragments were seen. The diagnosis of AGC-FN 
was made. Final histology proved to be endocervical adenocarcinoma in situ. (Papanicolaou 
stain, 200x) 
 
 
 
Fig. 12. Tubal metaplasia can closely mimic adenocarcinoma in situ. However, on close 
inspection, the abnormalities, such as crowding, nuclear elongation, hyperchromasia, and 
stratification are less severe. Locating terminal bars or cilia can help in confirmation, but 
they could not be identified in the smear we examined. The original diagnosis for this case 
was AGC-NOS, endocervical origin. (Papanicolaou stain, 400x) 
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Fig. 13. Lower uterine segment cells were composed of tightly packed uniform glandular 
cells in crowded honeycomb appearance. A stromal element is usually present in the 
surrounding area, which is an aid in the differential diagnosis. However, the stromal 
component is absent in the present case, the original diagnosis was AGC-NOS, cell origin 
also not otherwise specified. (Papanicolaou stain, 400x) 
4. Discussion 
The TBS was first introduced in 1988 for reporting cervical/vaginal cytology findings 
(National Cancer Institute Workshop, 1989). Revisions were made in 2001 to improve its 
sensitivity and specificity. In terms of categories of atypical glandular cells, In the 1988 
version these cells were defined as “atypical glandular cells of undetermined significance 
(AGUS)”. In the current 2001 version (Solomon, 2002), this nomenclature has changed to 
“atypical glandular cells, not otherwise specified (AGC-NOS)” and “atypical glandular cells, 
favor neoplastic (AGC-FN). Subclassification of cell origin (endocervical, endometrial, or not 
otherwise specified) should be done whenever possible. The TBS 2001 reporting system was 
proved to be better for detecting underlying gynecological lesions, including precursors and 
invasive malignant diseases in many reports (Behtash, 2007; Duska, 1998; Jeng, 2003; 
Koonings, 2001; Lai, 2008; Manetta, 1999; Mood, 2006; Soofer, 2000). The incidence of 
abnormal pathology ranged from 8.2% to 53%. Most studies defined abnormal pathology as 
precursors and invasive malignant diseases. Low grade squamous intra-epithelial lesions 
(LSIL) were excluded. The invasive malignancies may originate not only from uterine cervix 
and corpus but also extra-uterine organs, such as fallopian tube, ovary, colon and rectum. In 
this current report, we found that endometrial cancer was by far the most common 
malignant disease, 38 in 53 cases (72%), diagnosed in the AGC smears (Table 2). This was 
the highest data ever reported. The reason may be that since our previous observation of the 
importance of endometrial debris (Lai, 2008), the screeners paid much attention to this kind 
of cytology findings. The sensitivity of reporting endometrial debris increased and then 
detected more endometrial cancers.  
The concept of subclassification of AGC to NOS and FN categories as an important predictor 
for the risk of abnormal pathology was further supported in the current study (Table 3). The 
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subgroup of AGC-N, EM had the highest rate of abnormal pathology, followed by AGC-
NOS, EM, AGC-N and AGC-NOS; 18 of 21 (86%), 30 of 75 (40%), 4 of 11 (36%) and 24 of 83 
(29%), respectively. The difference was significant. (P<0.001) Women with AGC-N were 
more likely to have significant pathology (22 in 32 (69%)) compared with those with AGC-
NOS (54 in 158 (34%)). It was statistically significant. (P<0.001) The results were in 
accordance with other previous studies (Adhya, 2009; Behtash, 2007; Sawangsang, 2011; 
Westin, 2008; Zhao, 2009). They also confirmed the high risk nature of AGC smears. They 
have consistently demonstrated that the rate of abnormal pathology was significantly high if 
the AGC smears further classified as favoring neoplasia (41%-70%).  
Since we have observed the importance of endometrial debris in our previous report (Lai, 
2008), in the current study, only endometrial origin smears were calculated separately in 
order to strengthen the importance of this factor. The endocervical and not otherwise 
specified origins were counted together. The subgroup of AGC-N, EM had the highest rate 
of abnormal pathology, followed by AGC-NOS, EM, AGC-N and AGC-NOS; 18 of 21 (86%), 
30 of 75 (40%), 4 of 11 (36%) and 24 of 83 (29%), respectively. The difference was significant. 
(P<0.001) The endometrial origin addressed cases had more abnormal pathology results 
than those not being addressed, 48 of 96 (50%) v.s. 28 of 94 (30%). (P=0.004) (Table 3) The 
results further confirmed the importance of cell origin of AGC, especially the endometrial 
origin. The predictive value of background endometrial debris such as histiocytes for 
endometrial pathology in Pap smears has been a subject of controversy. Some studies have 
suggested a significant finding but the others didn’t (Iavazzo, 2008; Koss, 1962; Nassar, 2003; 
Ng, 1974; Nguyen, 1998; Wen, 2003).  The controversy is understandable, because the biopsy 
rate and the yield of endometrial neoplasm in these patients were relatively low in the past. 
According to Browne’s study (Browne, 2005), they found a 5-fold increase in the frequency 
with which endometrial cells were reported after the implementation of the TBS 2001. This 
then resulted in 25.2% of biopsies, a 1.3 fold increase in the overall number of tissue proof. 
Our another study (Lai, in press) of the importance of endometrial debris also revealed 
similar results. It showed that even in the absence of AGC, the presence of endometrial 
debris rather than the menopausal status was more related to the rate of biopsy procedure 
and a malignant pathology result. Degenerative necrotic debris is a significant risk factor for 
endometrial pathology, regardless of the presence or absence of AGC. Although the cervical 
screening program is not designed to detect endometrial lesions, early detection of any such 
cases is possible and is a bonus to be beneficial for these patients by identifying the 
significant degenerative endometrial debris in the Pap smears. Finally, another characteristic 
dirty mucinous background cytomorphology indicating endocervical adenocarcinoma 
observed in our series, being limited number of cases at present, will be continuously 
studied to investigate its sensitivity and specificity.  
5. Conclusion 
In the current study, AGC smears were associated with a high prevalence of abnormal 
pathology, including precursors and malignant diseases. Furthermore, the results of 
separations between “not otherwise specified” v.s. “favor neoplastic’ and “endometrial 
origin” was statistically significant. Endometrial cancers were the most common neoplasm 
in the AGC patients. The above findings supported the TBS 2001 for subcategories of AGC 
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and subclassifications of cell origins and the appropriate management algorithm of the 
guidelines of ASCCP 2006.  
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